287 related articles for article (PubMed ID: 32721098)
1. Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
Rai R; Yadav SS; Pan H; Khan I; O'Connor J; Alshalalfa M; Davicioni E; Taioli E; Elemento O; Tewari AK; Yadav KK
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1153. PubMed ID: 32721098
[TBL] [Abstract][Full Text] [Related]
2. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.
Devaney JM; Wang S; Furbert-Harris P; Apprey V; Ittmann M; Wang BD; Olender J; Lee NH; Kwabi-Addo B
Epigenetics; 2015; 10(4):319-28. PubMed ID: 25864488
[TBL] [Abstract][Full Text] [Related]
4. Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity.
Apprey V; Wang S; Tang W; Kittles RA; Southerland WM; Ittmann M; Kwabi-Addo B
Anticancer Res; 2019 Nov; 39(11):5861-5866. PubMed ID: 31704810
[TBL] [Abstract][Full Text] [Related]
5. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
[TBL] [Abstract][Full Text] [Related]
6. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.
Ali HEA; Lung PY; Sholl AB; Gad SA; Bustamante JJ; Ali HI; Rhim JS; Deep G; Zhang J; Abd Elmageed ZY
Sci Rep; 2018 Nov; 8(1):16335. PubMed ID: 30397274
[TBL] [Abstract][Full Text] [Related]
8. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.
Petrovics G; Price DK; Lou H; Chen Y; Garland L; Bass S; Jones K; Kohaar I; Ali A; Ravindranath L; Young D; Cullen J; Dorsey TH; Sesterhenn IA; Brassell SA; Rosner IL; Ross D; Dahut W; Ambs S; Figg WD; Srivastava S; Dean M
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):406-410. PubMed ID: 30542053
[TBL] [Abstract][Full Text] [Related]
10. Epigenome-Wide Association Study of Prostate Cancer in African Americans Identifies DNA Methylation Biomarkers for Aggressive Disease.
Xu Y; Tsai CW; Chang WS; Han Y; Huang M; Pettaway CA; Bau DT; Gu J
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944472
[TBL] [Abstract][Full Text] [Related]
11. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
12. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
13. Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity.
Elliott B; Zackery DL; Eaton VA; Jones RT; Abebe F; Ragin CC; Khan SA
Carcinogenesis; 2018 Apr; 39(4):546-555. PubMed ID: 29474521
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic alterations in localized and advanced prostate cancer.
Lin PC; Giannopoulou EG; Park K; Mosquera JM; Sboner A; Tewari AK; Garraway LA; Beltran H; Rubin MA; Elemento O
Neoplasia; 2013 Apr; 15(4):373-83. PubMed ID: 23555183
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
[TBL] [Abstract][Full Text] [Related]
16. Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer.
Creighton CJ; Zhang F; Zhang Y; Castro P; Hu R; Islam M; Ghosh S; Ittmann M; Kwabi-Addo B
Epigenetics; 2023 Dec; 18(1):2180585. PubMed ID: 37279148
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
Kwabi-Addo B; Wang S; Chung W; Jelinek J; Patierno SR; Wang BD; Andrawis R; Lee NH; Apprey V; Issa JP; Ittmann M
Clin Cancer Res; 2010 Jul; 16(14):3539-47. PubMed ID: 20606036
[TBL] [Abstract][Full Text] [Related]
18. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.
Theodore SC; Davis M; Zhao F; Wang H; Chen D; Rhim J; Dean-Colomb W; Turner T; Ji W; Zeng G; Grizzle W; Yates C
Oncotarget; 2014 Jun; 5(11):3512-25. PubMed ID: 25004396
[TBL] [Abstract][Full Text] [Related]
20. miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.
Yates C; Long MD; Campbell MJ; Sucheston-Campbell L
Front Biosci (Landmark Ed); 2017 Jan; 22(2):212-229. PubMed ID: 27814612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
